The name JBL is practically synonymous in the live entertainment industry with durable, powerful audio equipment, and they’ve been delivering some great things of late in keeping with their over ...
NEW YORK--(BUSINESS WIRE)--IRX Therapeutics, Inc. (IRX) today announced that the first patient has been dosed in an investigator-sponsored Phase 2 double-blind, randomized, placebo-controlled clinical ...
SAN FRANCISCO--(BUSINESS WIRE)--IRX Therapeutics, a discoverer and developer of proprietary therapies for the treatment of cancer and viral diseases, today announced at the J. P. Morgan Healthcare ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
NEW YORK - IRX Therapeutics, a privately-held company dedicated to the discovery and development of proprietary drugs for the treatment of cancer and viral diseases, today announced that it has raised ...
IRX Therapeutics, a New York-based drug developer focused on cancer and viral diseases, has raised $25 million in Series A funding. It has now raised a total of $65 million. No investor information ...
IndulgeRx Brands Inc secures USPTO IRX FOODSCORE® Trademarks; World’s first AI platform delivering personal Relevant ...
Next, the researchers explored whether Irx genes play a role in species outside the fish tank. To do so, Crump's team collaborated with the neighboring labs of Justin Ichida, Francesca Mariani and ...
BROOKLYN, N.Y.--(BUSINESS WIRE)-- Brooklyn ImmunoTherapeutics, Inc. (NYSE American: BTX) ("Brooklyn"), a biopharmaceutical company focused on exploring the role that cytokine and gene editing/cell ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results